FREE Shipping on all US Orders
From Root to Ritual
Biotin and hair loss: the honest picture from a 2026 systematic review — who it helps, who it doesn't, and why most people taking it are wasting their money.
In brief: Biotin (vitamin B7) is the most widely purchased hair supplement in the world. A May 2026 systematic review — the most comprehensive rev...
Hair fibers and scalp concealers: the honest guide to what works, what doesn't, and the one risk most people don't know about.
In brief: Hair fibers and scalp concealers create a genuine cosmetic improvement for thinning areas — they are not a treatment but they are a leg...
Collagen peptides and hair: what a 2026 RCT actually found — and why the mechanism matters more than the marketing.
In brief: A January 2026 randomized double-blind placebo-controlled trial of 100 adults taking 2000mg collagen peptides daily for 24 weeks found ...
Topical minoxidil: how it actually works, why it doesn't work for everyone, and the enzyme question your dermatologist probably hasn't mentioned.
Topical minoxidil is the only FDA-approved treatment for female
pattern hair loss. Up to 60% of women see noticeably thicker hair
after 8 months. But it requires conversion by a scalp enzyme —
sulfotransferase — to become biologically active. Women with low
sulfotransferase activity are non-responders to topical minoxidil
but typically respond well to the oral version. The shedding phase
in the first 4-8 weeks is not failure — it is how the treatment works.
Here is the complete honest guide.
Hair loss after menopause affects up to 52% of women — and the biology is different from perimenopause. Here is what's actually happening.
Up to 52% of postmenopausal women experience noticeable hair thinning
— making it the most common dermatological concern of the postmenopausal
years. A May 2025 clinical review (Gupta et al., PubMed) confirmed the
mechanism: estrogen decline shortens anagen, androgens become relatively
dominant, and follicles already primed for AGA begin miniaturising faster.
A November 2025 Frontiers in Pharmacology review confirmed saw palmetto,
rosemary, and phytoestrogen-containing botanicals have emerging evidence
for this specific population. Here is the full picture.
Hair loss and hair breakage are completely different problems — with completely different fixes. Here is how to tell which one you have.
Hair loss originates at the follicle — the strand falls out from the
root. Hair breakage happens along the shaft — strands snap before
reaching full length. Both make hair look thinner but require
completely different approaches. The simplest diagnostic tool:
look at the strand. White bulb at the end = follicle-origin shedding.
Short, jagged, no bulb = breakage. Getting this wrong means treating
the wrong problem for months.
How often should you wash your hair if you're experiencing hair loss? The answer is probably more often than you think.
A study of over 1,500 participants found hair quality satisfaction
highest in people who wash 5-6 times per week. A review medically
approved by the American Hair Loss Association in April 2026 found
that for people with AGA, infrequent washing can lead to sebum
buildup, increased inflammation, microbial imbalance, and oxidative
stress — all of which may accelerate follicular miniaturisation.
The "no-poo" movement has it backwards for people with hair loss.
Here is the evidence-based answer — with the honest exceptions.
Scalp pain at the hair root has a name — and a surprisingly specific set of causes. Here is what trichodynia actually is.
Scalp pain, tenderness, or burning at the hair root — especially
during active shedding — has a medical name: trichodynia. It affects
approximately one-third of patients with trichological disorders and
is significantly more common in women. A January 2025 study found
tissue substance P levels 5x higher in trichodynia AGA patients vs
controls. A June 2026 study found botulinum toxin relieved it in 9
out of 10 treatment-resistant cases. And a 2025 JDIN study confirmed
scalp pain location offers diagnostic clues about which type of hair
loss you have. Here is the complete picture.
Thyroid hair loss: why a normal TSH doesn't rule it out — and the test most panels miss.
Thyroid disorders affect up to 50% of patients with hair loss, per
the British Journal of Dermatology. A 2025 study of 100 women with
hair loss vs 100 controls found TSH and free T4 were significantly
lower in the hair loss group — both within normal range. TSH-only
testing misses T3 conversion problems. Biotin supplements interfere
with thyroid test results. And the outer eyebrow sign is more
sensitive than any blood test for early thyroid hair loss. Here is
the complete picture.
Your ferritin is "normal." That number might still be causing your hair loss.
Iron deficiency affects approximately 72% of women experiencing hair
loss — making it the most common nutritional cause. Standard labs
flag deficiency at 12-15 ng/mL. The hair-optimal ferritin target is
40-70 ng/mL. Women with ferritin at or below 30 ng/mL have 21 times
higher odds of telogen effluvium vs those above. And ferritin is an
acute-phase reactant — inflammation can falsely inflate it, masking
true depletion. Here is what your ferritin result actually means for
your hair.
CCCA is the most common scarring alopecia in Black women — and a 2026 UCLA study found it takes longer to diagnose than any other scarring hair loss. Here is why that matters.
Central centrifugal cicatricial alopecia (CCCA) affects 2.7-5.7% of
Black women and is the most common scarring alopecia in this population.
A February 2026 UCLA study published in JDIN found CCCA has the longest
time to diagnosis of any scarring alopecia — a health disparity with
direct consequences, since scarred follicles cannot be restored.
A May 2025 Mayo Clinic case-control study of 54 patients confirmed CCCA
patients are significantly less likely to improve with treatment than
other scarring alopecias. Here is what to know, and why early recognition
changes everything.
Zinc and hair loss: a 2025 study just said routine zinc testing isn't recommended. Here is what that means — and when zinc actually matters.
A November 2025 cross-sectional study in Healthcare (Liran et al.)
found that patients with hair loss had slightly lower zinc levels than
controls — but the difference was minor, within the normal range,
and not clinically significant. The study concluded that routine zinc
testing is not recommended when evaluating hair loss. And yet zinc
genuinely matters in alopecia areata and telogen effluvium. And
excess zinc causes hair loss by interfering with iron. Here is the
honest picture.